Biora Therapeutics (BIOR) Misses Q3 EPS by 504c

Biora Therapeutics (NASDAQ: BIOR) reported Q3 EPS of ($5.04). Revenue for the quarter came in at $30 thousand.

For earnings history and earnings-related data on Biora Therapeutics (BIOR) click here.

You May Also Be Interested In

• Sprinklr (CXM) Tops Q2 EPS by 1c, Offers Guidance
• Ciena (CIEN) call put ratio 1 call to 1.6 puts into quarter results
• Increasing unusual call volume: GPRO ALLY PCG RSI EYPT NRG VYX DPRO GTLB CWH